AKTX - Akari Therapeutics Plc
0.257
0.006 2.257%
Share volume: 756,181
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$0.25
0.01
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-19-2024 | 11-19-2024 | 05-14-2025 | 08-13-2025 | 11-13-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 5.989 M | 5.555 M | 1.852 M | 3.525 M | 3.119 M | 2.224 M | |
| Selling general and admin | 3.710 M | 2.241 M | 1.709 M | 2.712 M | 2.452 M | 1.975 M | |
| Research and development | 2.279 M | 3.314 M | 143.000 K | 813.000 K | 667.000 K | 249.000 K | |
| Total expenses | 5.989 M | 7.449 M | 2.927 M | 3.525 M | 3.119 M | 7.404 M | |
| 24.38% | -60.71% | 20.43% | -11.52% | 137.38% | |||
| Operating income | -5.989 M | -7.449 M | -2.927 M | -3.525 M | -3.119 M | -7.404 M | |
| Ebit | -5.566 M | -7.509 M | -2.829 M | -3.704 M | -1.845 M | -6.401 M | |
| Pretax income | -5.566 M | -7.558 M | -2.895 M | -3.705 M | -1.895 M | -7.488 M | |
| 35.79% | -61.70% | 27.98% | -48.85% | 295.15% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -1.088 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.566 M | -7.558 M | -2.895 M | -3.705 M | -1.895 M | -6.400 M | |
| -35.79% | 61.70% | -27.98% | 48.85% | -237.73% |